PROSPR
DEAD

Serial Number

97209650

Owner

INanoBio Inc

Filing Date

Jan 9, 2022

Add to watchlist:

No watchlists yet
View on USPTO

PROSPR Trademark

Serial Number: 97209650

PROSPR is a trademark filed by INanoBio Inc on January 9, 2022. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). The application is currently no longer active.

Owner Contact Info

INanoBio Inc (10 trademarks)

7201 E Henkel Way, Suite 285
Scottsdale, AZ 85255

Entity Type: 03

Trademark Details

Filing Date

January 9, 2022

Registration Date

Not Registered

Published for Opposition

December 27, 2022

Goods & Services

Diagnostic agents, preparations and substances for medical purposes; Diagnostic biomarker reagents for medical purposes; Diagnostic media for bacteriological cultures; Diagnostic preparations for medical and veterinary use; Diagnostic preparations for medical or veterinary purposes; Diagnostic preparations for medical purposes; Diagnostic preparations for veterinary purposes; Diagnostic reagents and contrast media for medical use; Diagnostic reagents for medical use; Protein arrays for diagnosing infectious diseases; Protein arrays for diagnosing cancer; Protein arrays for diagnosing chronic diseases; Protein arrays for medical diagnosis purposes; Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, infectious diseases; Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, cancer; Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, allergies; Drug testing kits comprised of medical diagnostic reagents and assays for testing body fluids; Medical diagnostic reagents; Medical diagnostic reagents for the analysis of body fluids; Medical diagnostic reagents and assays for testing body fluids for microorganisms; Medical diagnostic reagents and assays for testing of body fluids; Reagents and media for medical and veterinary diagnostic purposes

Assays and reagents for use in genetic research; Assays for research purposes; Biochemical preparations for scientific purposes; Biochemical reagents commonly known as probes, for detecting and analyzing molecules in protein or nucleotide arrays; Biochemical reagents used for non-medical purposes; Biochemicals for in vitro and in vivo scientific use; Biochemicals, namely, monoclonal antibodies for in vitro scientific or research use; Biochemicals, namely, polynucleotides for in vitro and in vivo scientific and research purposes; Biochemicals, namely, polypeptides for in vitro research use; Biochemicals, namely, precursors for in vitro genetic engineering use; Diagnostic preparations for clinical or medical laboratory use; Diagnostic preparations for scientific or research use; Diagnostic preparations for scientific or research use other than for medical use; Diagnostic preparations other than for medical or veterinary purposes; Diagnostic preparations used in science; Diagnostic preparations, other than for medical or veterinary purposes; Diagnostic reagents for clinical or medical laboratory use; Diagnostic reagents for scientific or research use; Diagnostic reagents for scientific use; Protein arrays and nucleotide arrays for scientific and medical research; Protein in raw material form for scientific and medical research; Proteins for the food industry; Proteins for use in manufacture; Catalysts for chemical and biochemical processes; Chemicals for use in the purification of proteins for in vitro use; Diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology; Enzymes for use in protein hydrolysis; Laboratory chemicals, namely, an antibody reagent used for the detection of antigens in cell and tissue analysis for in vitro diagnostic use

Apparatus for DNA and RNA testing for medical purposes; Apparatus used in implementing diagnosis tests designed to detect the abnormal prion protein; Diagnostic apparatus for the detection of cancer; Blood testing apparatus, namely, blood collecting tubes; Blood testing apparatus, namely, blood sampling tubes; Flow cytometers for medical diagnostic uses; Genetic testing apparatus for medical purposes; Immunochemical testing apparatus for medical use; Medical diagnostic apparatus for analyzing and measuring electrolytes in the body; Medical diagnostic apparatus for detecting cancer; Medical diagnostic apparatus for testing DNA and RNA samples; Medical diagnostic apparatus for testing for viruses; Medical diagnostic apparatus, analytical apparatus for medical purposes and blood pressure measuring apparatus; Medical diagnostic instruments for the analysis of body fluids; Medical apparatus and instrument for diagnostic use, namely, apparatus for medical diagnostic testing in the fields of cancer or other tissue-based diagnostic testing, cytology and cell-based testing; Medical diagnostic apparatus for testing protein, antibody biomarkers; Medical diagnostic apparatus for testing phenotypic biomarkers incorporating recorded operating system software; Medical diagnostic apparatus for testing protein binding and interactions incorporating recorded software for kinetic analysis; Medical instruments, namely, biosensors for detecting infectious diseases; Organoleptic diagnostic testing apparatus for medical, dental or cosmetic use; Sample preparation device for medical diagnostic uses

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Jul 30, 2025 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Jul 29, 2025 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 20, 2024 EXRA
SOU EXTENSION 3 GRANTED
Aug 20, 2024 EX3G
SOU EXTENSION 3 FILED
Aug 20, 2024 EXT3
SOU TEAS EXTENSION RECEIVED
Aug 20, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 17, 2024 EXRA
SOU EXTENSION 2 GRANTED
Feb 16, 2024 EX2G
SOU EXTENSION 2 FILED
Feb 16, 2024 EXT2
SOU TEAS EXTENSION RECEIVED
Feb 16, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 19, 2023 EXRA
SOU EXTENSION 1 GRANTED
Aug 17, 2023 EX1G
SOU EXTENSION 1 FILED
Aug 17, 2023 EXT1
SOU TEAS EXTENSION RECEIVED
Aug 17, 2023 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Feb 21, 2023 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 27, 2022 NPUB
PUBLISHED FOR OPPOSITION
Dec 27, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 7, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 21, 2022 CNSA
EXAMINER'S AMENDMENT ENTERED
Nov 21, 2022 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Nov 21, 2022 GNEN
EXAMINERS AMENDMENT E-MAILED
Nov 21, 2022 GNEA
EXAMINERS AMENDMENT -WRITTEN
Nov 21, 2022 CNEA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 10, 2022 GNRN
NON-FINAL ACTION E-MAILED
May 10, 2022 GNRT
NON-FINAL ACTION WRITTEN
May 10, 2022 CNRT
ASSIGNED TO EXAMINER
May 3, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 14, 2022 NWOS
NEW APPLICATION ENTERED
Jan 12, 2022 NWAP